Victory Capital Management
EXAS

Victory Capital Management’s Exact Sciences EXAS Stock Holding History

Victory Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,839
Closed -$5.26M – 2443
2025
Q4 		$5.26M Buy
51,839
+30,328
+141% +$2.44M ﹤0.01% 1294
2025
Q3 		$1.18M Sell
21,511
-646
-3% -$32.3K ﹤0.01% 1764
2025
Q2 		$1.18M Buy
22,157
+85
+0.4% +$4.32K ﹤0.01% 1773
2025
Q1 		$955K Sell
22,072
-19,248
-47% -$975K ﹤0.01% 1819
2024
Q4 		$2.32M Sell
41,320
-651
-2% -$40.5K ﹤0.01% 1461
2024
Q3 		$2.86M Sell
41,971
-16,449
-28% -$928K ﹤0.01% 1394
2024
Q2 		$2.47M Sell
58,420
-17,321
-23% -$953K ﹤0.01% 1379
2024
Q1 		$5.23M Sell
75,741
-674,487
-90% -$42.7M 0.01% 1223
2023
Q4 		$55.5M Buy
750,228
+239,840
+47% +$15.7M 0.06% 401
2023
Q3 		$34.8M Buy
510,388
+356,084
+231% +$30.2M 0.04% 537
2023
Q2 		$14.5M Buy
154,304
+27,549
+22% +$2.15M 0.02% 899
2023
Q1 		$8.6M Buy
126,755
+106,872
+538% +$6.87M 0.01% 1076
2022
Q4 		$984K Sell
19,883
-9
-0% -$368 ﹤0.01% 1748
2022
Q3 		$646K Sell
19,892
-129
-0.6% -$5.32K ﹤0.01% 1936
2022
Q2 		$789K Sell
20,021
-613
-3% -$32.8K ﹤0.01% 1853
2022
Q1 		$1.14M Sell
20,634
-41,558
-67% -$3.04M ﹤0.01% 1737
2021
Q4 		$4.84M Sell
62,192
-351
-0.6% -$31K ﹤0.01% 1335
2021
Q3 		$5.97M Sell
62,543
-20,539
-25% -$2.17M 0.01% 1281
2021
Q2 		$10.3M Sell
83,082
-485,523
-85% -$57.9M 0.01% 1116
2021
Q1 		$74.9M Sell
568,605
-10,058
-2% -$1.38M 0.08% 376
2020
Q4 		$76.7M Buy
578,663
+174,405
+43% +$21.1M 0.09% 354
2020
Q3 		$41.2M Sell
404,258
-34,914
-8% -$3.02M 0.05% 524
2020
Q2 		$38.2M Sell
439,172
-618,680
-58% -$49.4M 0.05% 518
2020
Q1 		$61.4M Sell
1,057,852
-542,342
-34% -$44M 0.05% 504
2019
Q4 		$148M Buy
1,600,194
+74,316
+5% +$6.53M 0.18% 136
2019
Q3 		$138M Buy
1,525,878
+491,338
+47% +$56M 0.18% 144
2019
Q2 		$122M Buy
1,034,540
+242,225
+31% +$24.4M 0.25% 90
2019
Q1 		$68.6M Buy
792,315
+18,413
+2% +$1.57M 0.16% 181
2018
Q4 		$48.8M Sell
773,902
-207,022
-21% -$14.2M 0.12% 245
2018
Q3 		$77.4M Sell
980,924
-214,015
-18% -$14M 0.16% 164
2018
Q2 		$71.4M Sell
1,194,939
-514,566
-30% -$27.7M 0.15% 179
2018
Q1 		$68.9M Buy
1,709,505
+519,945
+44% +$25.4M 0.15% 195
2017
Q4 		$62.5M Buy
1,189,560
+539,160
+83% +$28.8M 0.13% 233
2017
Q3 		$30.6M Sell
650,400
-182,210
-22% -$7.33M 0.07% 463
2017
Q2 		$29.4M Buy
+832,610
New +$25.7M 0.07% 463
2016
Q3 		– Sell
-545
Closed -$7K – 1794
2016
Q2 		$7K Buy
545
+11
+2% +$83 ﹤0.01% 1626
2016
Q1 		$4K Buy
534
+42
+9% +$269 ﹤0.01% 1657
2015
Q4 		$5K Buy
492
+27
+6% +$251 ﹤0.01% 1673
2015
Q3 		$8K Buy
465
+41
+10% +$942 ﹤0.01% 1608
2015
Q2 		$13K Buy
+424
New +$10.7K ﹤0.01% 1613

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Victory Capital Management's EXAS Position: Q1 2026 in Review

Victory Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 51,839 shares — an estimated $5.26M sold.

Victory Capital Management first reported a position in EXAS in Q2 2015 and held it in 40 quarters. The position peaked at $148M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Victory Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Victory Capital Management sold 51,839 Exact Sciences shares in Q1 2026, an estimated $5.26M.
  • Victory Capital Management first reported a position in Exact Sciences in Q2 2015 and held it in 40 quarters.
  • Victory Capital Management's Exact Sciences position peaked at $148M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.